media – Page 675 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

Eli Lilly gets a date with FDA experts for once-rejected rheumatoid arthritis drug baricitinib

Eli Lilly’s one-time blockbuster hopeful baricitinib $LLY is back and on track and ready to run a gamut of outside experts at the FDA.
- Source: Endpts
- 733
- March 23, 2018
baricitinib Company Insight FDA
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing

TCR2 Therapeutics Inc., an immuno-oncology company pioneering a novel class of T cell receptor (TCR)-based cellular therapies for solid tumors and blood cancers, announced today the completion of an oversubscribed Series B financing of $125 million.
- Source: tcr2
- 595
- March 23, 2018
blood cancer Market Views solid tumor TCR
Brain ‘Stethoscope’ Listens For Silent Seizures

Researchers have developed what they have dubbed a ‘brain stethoscope’, a device capable of turning EEG brain wave data into sound. The device is able to detect epileptic seizures that do not result in convulsions.
- Source: Neuroscience News
- 1,471
- March 23, 2018
medical device neuroscience Researches
Patient check-in platform Medical Mindset pulls in $1M

Patient engagement platform Medical Mindset just landed $1 million in investment capital. The company's platform allows patients to build a HIPAA-compliant health profile, which they can use to check into an appointment by swiping their smartphone.
- Source: MobiHealthNews
- 619
- March 23, 2018
Company Insights digital health mHealth
GSK pharma boss Miels rejigs commercial operations to stoke new launches Trelegy, Shingrix

GlaxoSmithKline's new CEO Emma Walmsley isn’t the only one shaking things up at the top of the British drugmaker.
- Source: fiercepharma.
- 812
- March 23, 2018
Company Insights GlaxoSmithKline Shingrixin vaccine
EMA starts review of Xtandi in non-metastatic prostate cancer

The EU medicines regulator has started its review of Astellas and Pfizer’s prostate cancer drug Xtandi in what looks likely to become a hotly contested indication - non-metastatic castration-resistant prostate cancer (nmCRPC).
- Source: pmlive
- 991
- March 23, 2018
Astellas Company Insights nmCRPC Pfizer Xtandi
Tooth Sensor Measures Intake of Sugar, Salt, Alcohol

Having an accurate record of food and alcohol intake is important for managing a number of diseases including diabetes, various cardiovascular conditions, and alcoholism. Currently, not much practical technology is available to do this aside from smartphone apps, and apps tend to be tedious and require constant vigilance of making sure to input all the data.
- Source: Med Gadget
- 1,448
- March 23, 2018
diabetes digital health Researches
Ddu Priority Products Recruitment Activity Online

In collaboration with Google, Facebook, Yahoo and LinkedIn, Ddu recently launched their priority products rally to help users on the platform capture business opportunities, hosting an online medical device product fair to get mass exposure for users' quality products.
- Source: Ddu
- 1,864
- March 22, 2018
Ddu News medical device
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases

Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan categories, today announced a global collaboration with Celgene Corporation (CELG) through a subsidiary, to develop new therapies for a broad range of neurodegenerative diseases.
- Source: finance.yahoo
- 583
- March 22, 2018
Market Views neurodegenerative preclinical
Artificial intelligence firm twoXAR raises $10M for partnering drive

Artificial intelligence company twoXAR—a specialist in separating signals from noise in data-rich drug discovery projects—has raised $10 million in a first-round financing led by SoftBank Ventures.
- Source: Fiercebiotech
- 684
- March 22, 2018
diabetes financing Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.